BRIDGEWATER, N.J. (AP) _ Insmed Inc. (INSM) on Friday reported a loss of $91.6 million in its fourth quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.19. Losses, adjusted for amortization costs, were $1.17 per share.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.11 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $9.8 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $5 million.
For the year, the company reported that its loss widened to $324.3 million, or $4.22 per share. Revenue was reported as $9.8 million.
Insmed shares have climbed 95 percent since the beginning of the year. The stock has risen almost 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM